Biotech for driving change
Now YOU can invest and become a shareholder in the company aiming to drive change on the biotechnology market
Our Vision
We empower scientists and engineers to simplify and accelerate progress in life science and bioprocessing
Market
The market is driven by favorable government initiatives owing to the growth of the biotechnology sector in developing countries, such as India and China. Government initiatives are oriented towards modernizing the drug regulatory pathway, standardizing clinical studies, improving reimbursement policies, and speeding up the product approval process, thereby offering lucrative growth opportunities to the market. In addition, in 2019, small molecules dominated the pharmaceutical compounds pipeline with around 22 U.S. FDA approvals as compared to eight large molecules (biotech). Around 4 out of every 10 drugs are biotech derived, This is driving the influx of emerging and innovative biotechnologies companies, further boosting the market revenue.
Why Invest with us?
Investors are treated like a bank with a better-than-average fixed rate of return of 12%
Investors are treated like a bank with a better-than-average fixed rate of return of 12%
Investors are treated like a bank with a better-than-average fixed rate of return of 12%
Investors are treated like a bank with a better-than-average fixed rate of return of 12%
Investment Summary
- Company : BIOTEC-C
- Corporate Address: 221 Est Main Street, California
- Type of security Offered: REG A
- Purchase Price of Security Offered: $125 per share
- Minimun Investment: $500
As Featured On
Incentives and Bonus
Investors who purchase over $25,000 worth of stock will receive 3 free months of ownership & service subscription*
Investors who purchase over $50,000 worth of stock will receive 6 free months of ownership & service subscription**
The investor who purchases the most stock in this campaign will receive a free all-expenses-paid trip for two to Atlis Headquarters in Mesa, AZ to test drive the XT, tour Atlis HQ, and meet the Atlis team.
Our Team
LEADERSHIP TEAM: HIGH-HORSEPOWER WITH AN INNOVATIVE TRACK RECORD
